|
2021
|
Invention
|
Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natu... |
|
2020
|
Invention
|
Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a s... |
|
2019
|
Invention
|
Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to... |
|
|
Invention
|
Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a co... |
|
|
Invention
|
Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript... |
|
2018
|
Invention
|
Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity. The p... |
|
|
Invention
|
Treatment of atonal homolog 1 (atoh1) related diseases by inhibition of natural antisense transcr... |
|
|
Invention
|
Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antise... |
|
|
Invention
|
Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript ... |
|
|
Invention
|
Treatment of adiponectin (adipoq) related diseases by inhibition of natural antisense transcript ... |
|
2017
|
Invention
|
Treatment of alpha-l-iduronidase (idua) related diseases by inhibition of natural antisense trans... |
|
|
Invention
|
Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense tran... |
|
|
Invention
|
Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural anti... |
|
|
Invention
|
Treatment of nanog related diseases by inhibition of natural antisense transcript to nanog. The p... |
|
|
Invention
|
Treatment of sodium channel, voltage-gated, alpha subunit (scna) related diseases by inhibition o... |
|
|
Invention
|
Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript ... |
|
|
Invention
|
Treatment of fibroblast growth factor 21 (fgf21) related diseases by inhibition of natural antise... |
|
|
Invention
|
Treatment of rnase h1 related diseases by inhibition of natural antisense transcript to rnase h1.... |
|
|
Invention
|
Treatment of par4 related diseases by inhibition of natural antisense transcript to par4. The pre... |
|
|
Invention
|
Treatment of frataxin (fxn) related diseases by inhibition of natural antisense transcript to fxn... |
|
2016
|
Invention
|
Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of... |
|
|
Invention
|
Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural ... |
|
|
Invention
|
Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related disease by inhibition of natural... |
|
|
Invention
|
Treatment of discs large homolog (dlg) related diseases by inhibition of natural antisense transc... |
|
|
Invention
|
Treatment of colony-stimulating factor 3 (csf3) related diseases by inhibition of natural antisen... |
|
2015
|
Invention
|
Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to... |
|
|
Invention
|
Treatment of sex hormone binding globulin (shbg) related diseases by inhibition of natural antise... |
|
|
Invention
|
Treatment of membrane bound transcription factor peptidase, site 1 (mbtps1) related diseases by i... |
|
|
Invention
|
Treatment of interferon-related developmental regulator 1 (ifrd1) related diseases by inhibition ... |
|
|
Invention
|
Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcrip... |
|
|
Invention
|
Treatment of lcat gene related diseases by inhibition of a natural antisense transcript to lcat. ... |
|
|
Invention
|
Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an ... |
|
|
Invention
|
Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural a... |
|
|
Invention
|
Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense tran... |
|
|
Invention
|
Treatment of insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antise... |
